 SEATTLE, Sept. 09, 2022 GLOBE NEWSWIRE -- Sana Biotechnology, Inc. NASDAQ: SANA, a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentations at two investor conferences in September. The presentations will feature a business overview and update by Steve Harr, Sanas President and Chief Executive Officer. 